Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams

Traditional studies on the evolution of antibiotic resistance development use approaches that can range from laboratory-based experimental studies, to epidemiological surveillance, to sequencing of clinical isolates. However, evolutionary trajectories also depend on the environment in which selecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Colque, Claudia A., Albarracín Orio, Andrea Georgina, Tomatis, Pablo Emiliano, Dotta, Gina, Moreno, Diego M., Hedemann, Laura Gabriela, Hickman, Rachel, Madsen Sommer, Lea Mette, Feliziani, Sofía, Moyano, Alejandro José, Bonomo, Robert, Johansen, Helle Krogh, Molin, Søren, Vila, Alejandro, Smania, Andrea M.
Formato: Artículo acceptedVersion
Lenguaje:Español
Publicado: 2022
Materias:
Acceso en línea:http://pa.bibdigital.ucc.edu.ar/3687/1/A_Colque_Albarrac%C3%ADnOrio_Tomatis_Dotta_Moreno_Hedemann_Hickman_Sommer_Feliziani_Moyano_Bonomo_Johansen_Molin_Vila_Smania.pdf
Aporte de:
id I38-R144-3687
record_format dspace
institution Universidad Católica de Córdoba
institution_str I-38
repository_str R-144
collection Producción Académica Universidad Católica de Córdoba (UCCor)
language Español
orig_language_str_mv spa
topic R Medicina (General)
spellingShingle R Medicina (General)
Colque, Claudia A.
Albarracín Orio, Andrea Georgina
Tomatis, Pablo Emiliano
Dotta, Gina
Moreno, Diego M.
Hedemann, Laura Gabriela
Hickman, Rachel
Madsen Sommer, Lea Mette
Feliziani, Sofía
Moyano, Alejandro José
Bonomo, Robert
Johansen, Helle Krogh
Molin, Søren
Vila, Alejandro
Smania, Andrea M.
Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams
topic_facet R Medicina (General)
description Traditional studies on the evolution of antibiotic resistance development use approaches that can range from laboratory-based experimental studies, to epidemiological surveillance, to sequencing of clinical isolates. However, evolutionary trajectories also depend on the environment in which selection takes place, compelling the need to more deeply investigate the impact of environmental complexities and their dynamics over time. Herein, we explored the within-patient adaptive long-term evolution of a Pseudomonas aeruginosa hypermutator lineage in the airways of a cystic fibrosis (CF) patient by performing a chronological tracking of mutations that occurred in different subpopulations; our results demonstrated parallel evolution events in the chromosomally encoded class C b-lactamase (blaPDC). These multiple mutations within blaPDC shaped diverse coexisting alleles, whose frequency dynamics responded to the changing antibiotic selective pressures for more than 26 years of chronic infection. Importantly, the combination of the cumulative mutations in blaPDC provided structural and functional protein changes that resulted in a continuous enhancement of its catalytic efficiency and high level of cephalosporin resistance. This evolution was linked to the persistent treatment with ceftazidime, which we demonstrated selected for variants with robust catalytic activity against this expanded-spectrum cephalosporin. A “gain of function” of collateral resistance toward ceftolozane, a more recently introduced cephalosporin that was not prescribed to this patient, was also observed, and the biochemical basis of this cross-resistance phenomenon was elucidated. This work unveils the evolutionary trajectories paved by bacteria toward a multidrug-resistant phenotype, driven by decades of antibiotic treatment in the natural CF environmental setting.
format Artículo
Artículo
acceptedVersion
author Colque, Claudia A.
Albarracín Orio, Andrea Georgina
Tomatis, Pablo Emiliano
Dotta, Gina
Moreno, Diego M.
Hedemann, Laura Gabriela
Hickman, Rachel
Madsen Sommer, Lea Mette
Feliziani, Sofía
Moyano, Alejandro José
Bonomo, Robert
Johansen, Helle Krogh
Molin, Søren
Vila, Alejandro
Smania, Andrea M.
author_facet Colque, Claudia A.
Albarracín Orio, Andrea Georgina
Tomatis, Pablo Emiliano
Dotta, Gina
Moreno, Diego M.
Hedemann, Laura Gabriela
Hickman, Rachel
Madsen Sommer, Lea Mette
Feliziani, Sofía
Moyano, Alejandro José
Bonomo, Robert
Johansen, Helle Krogh
Molin, Søren
Vila, Alejandro
Smania, Andrea M.
author_sort Colque, Claudia A.
title Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams
title_short Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams
title_full Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams
title_fullStr Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams
title_full_unstemmed Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams
title_sort longitudinal evolution of the pseudomonas-derived cephalosporinase (pdc) structure and activity in a cystic fibrosis patient treated with β-lactams
publishDate 2022
url http://pa.bibdigital.ucc.edu.ar/3687/1/A_Colque_Albarrac%C3%ADnOrio_Tomatis_Dotta_Moreno_Hedemann_Hickman_Sommer_Feliziani_Moyano_Bonomo_Johansen_Molin_Vila_Smania.pdf
work_keys_str_mv AT colqueclaudiaa longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT albarracinorioandreageorgina longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT tomatispabloemiliano longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT dottagina longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT morenodiegom longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT hedemannlauragabriela longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT hickmanrachel longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT madsensommerleamette longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT felizianisofia longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT moyanoalejandrojose longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT bonomorobert longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT johansenhellekrogh longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT molinsøren longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT vilaalejandro longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
AT smaniaandream longitudinalevolutionofthepseudomonasderivedcephalosporinasepdcstructureandactivityinacysticfibrosispatienttreatedwithblactams
bdutipo_str Repositorios
_version_ 1764820536274190337